Literature DB >> 25662891

Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX.

Jason Zhu1, Jonathan R Strosberg, Evan Dropkin, John H Strickler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25662891     DOI： 10.1007/s12029-015-9689-0

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  17 in total

1.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

2.  Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

Authors:  P M Hoff; R Ansari; G Batist; J Cox; W Kocha; M Kuperminc; J Maroun; D Walde; C Weaver; E Harrison; H U Burger; B Osterwalder; A O Wong; R Wong
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

3.  Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Authors:  Emilio Bajetta; Laura Catena; Giuseppe Procopio; Sara De Dosso; Ettore Bichisao; Leonardo Ferrari; Antonia Martinetti; Marco Platania; Elena Verzoni; Barbara Formisano; Roberto Bajetta
Journal:  Cancer Chemother Pharmacol       Date:  2006-08-26       Impact factor: 3.333

4.  Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Authors:  E Van Cutsem; C Twelves; J Cassidy; D Allman; E Bajetta; M Boyer; R Bugat; M Findlay; S Frings; M Jahn; J McKendrick; B Osterwalder; G Perez-Manga; R Rosso; P Rougier; W H Schmiegel; J F Seitz; P Thompson; J M Vieitez; C Weitzel; P Harper
Journal:  J Clin Oncol       Date:  2001-11-01       Impact factor: 44.544

5.  A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).

Authors:  Hirotsugu Kenmotsu; Seiji Niho; Takeo Ito; Yuichi Ishikawa; Masayuki Noguchi; Hirohito Tada; Ikuo Sekine; Shun-Ichi Watanabe; Masahiro Yoshimura; Nobuyuki Yamamoto; Fumihiro Oshita; Kaoru Kubota; Kanji Nagai
Journal:  Lung Cancer       Date:  2014-03-13       Impact factor: 5.705

6.  First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.

Authors:  Jonathan R Strosberg; Robert L Fine; Junsung Choi; Aejaz Nasir; Domenico Coppola; Dung-Tsa Chen; James Helm; Larry Kvols
Journal:  Cancer       Date:  2010-09-07       Impact factor: 6.860

7.  The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.

Authors:  Jonathan R Strosberg; Domenico Coppola; David S Klimstra; Alexandria T Phan; Matthew H Kulke; Gregory A Wiseman; Larry K Kvols
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 8.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

9.  Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

Authors:  T R Halfdanarson; K G Rabe; J Rubin; G M Petersen
Journal:  Ann Oncol       Date:  2008-05-30       Impact factor: 32.976

Review 10.  Neuroendocrine tumors of the pancreas.

Authors:  Florian Ehehalt; Hans D Saeger; C Max Schmidt; Robert Grützmann
Journal:  Oncologist       Date:  2009-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.